Registro:

Referencias:

• Alves, C.M., Galectin-3 plays a modulatory role in the life span and activation of murine neutrophils during early toxoplasma gondii infection (2010) Immunobiology, 215, pp. 475-485
• Balogh, A., Placental protein 13 (pp13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome (2011) Am. J. Obstet. Gynecol., 205 (15), pp. e1-e14
• Barondes, S.H., Galectins. Structure and function of a large family of animal lectins (1994) J. Biol. Chem., 269, pp. 20807-20810
• Blois, S.M., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nat. Med., 13, pp. 1450-1457
• Brewer, C.F., Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions (2002) Curr. Opin. Struct. Biol., 12, pp. 616-623
• Camby, I., Galectin-1: a small protein with major functions (2006) Glycobiology, 16, pp. 137R-157R
• Carlino, C., Recruitment of circulating nk cells through decidual tissues: a possible mechanism controlling nk cell accumulation in the uterus during early pregnancy (2008) Blood, 111, pp. 3108-3115
• Cattaneo, V., Galectin-8 tandem-repeat structure is essential for t-cell proliferation but not for co-stimulation (2011) Biochem. J., 434, pp. 153-160
• Chen, H.Y., Roles of galectin-3 in immune responses (2005) Arch. Immunol. Ther. Exp., 53, pp. 497-504
• Choe, Y.S., Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation (1997) Mol. Reprod. Dev., 48, pp. 261-266
• Cindrova-Davies, T., Oxidative stress, gene expression, and protein changes induced in the human placenta during labor (2007) Am. J. Pathol., 171, pp. 1168-1179
• Colnot, C., Embryonic implantation in galectin 1/galectin 3 double mutant mice (1998) Dev. Dyn., 211, pp. 306-313
• Cooper, D.N., Galectinomics: finding themes in complexity (2002) Biochim. Biophys. Acta, 1572, pp. 209-231
• Cordo-Russo, R.I., HA in pathological and physiological processes: An overview of HA metabolism in cancer and pregnancy (2012) Curr. Trend. in Immunol, 13, pp. 81-94
• Crider-Pirkle, S., Cubilin, a binding partner for galectin-3 in the murine utero-placental complex (2002) J. Biol. Chem., 277, pp. 15904-15912
• Delgado, V.M., Modulation of endothelial cell migration and angiogenesis: a novel function for the Tandem-repeat Lectin galectin-8 (2011) FASEB J., 25, pp. 242-254
• Dong, M., The effect of trophoblasts on t lymphocytes: possible regulatory effector molecules - a proteomic analysis (2008) Cell. Physiol. Biochem., 21, pp. 463-472
• Douglas, N.C., Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse (2009) Endocrinology, 150, pp. 3845-3854
• Eshkar Sebban, L., The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation (2007) J. Immunol., 179, pp. 1225-1235
• Farina, A., Performance of messenger rNAS circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks (2010) Am. J. Obstet. Gynecol., 203 (57), pp. e1-e7
• Froehlich, R., Galectin fingerprinting detects differences in expression profiles between bovine endometrium and placentomes as well as early and late gestational stages (2012) Placenta, 33, pp. 195-201
• Gizurarson, S., Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents (2013) Fetal Diagn. Ther., 33, pp. 257-264
• Halder, J.B., Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation (2000) Genesis, 26, pp. 213-224
• Harskamp, R.E., Zeeman, G.G., Preeclampsia: at risk for remote cardiovascular disease (2007) Am. J. Med. Sci., 334, pp. 291-295
• Hernandez, J.D., Baum, L.G., Ah sweet mystery of death! Galectins and control of cell fate (2002) Glycobiology, 12, pp. 127R-136R
• Herse, F., Cytochrome p450 subfamily 2j polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia (2012) Circulation, 126, pp. 2990-2999
• Heusschen, R., Profiling lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy (2013) Biol. Reprod., 88, p. 22
• Hirota, Y., Galectin-1 markedly reduces the incidence of resorptions in mice missing immunophilin fkbp52 (2012) Endocrinology, 153, pp. 2486-2493
• Hsieh, S.H., Galectin-1 a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27, pp. 3746-3753
• Huppertz, B., Placental origins of preeclampsia: challenging the current hypothesis (2008) Hypertension, 51, pp. 970-975
• Huppertz, B., Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia (2013) Hum. Reprod. Update, 19, pp. 391-405
• Iglesias, M.M., Purification of galectin-3 from ovine placenta: developmentally regulated expression and immunological relevance (1998) Glycobiology, 8, pp. 59-65
• Jeschke, U., Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal IUGR, preeclamptic and HELLP placentas (2007) Placenta, 28, pp. 1165-1173
• Kliman, H.J., Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia (2012) Reprod. Sci., 19, pp. 16-30
• Kolundzic, N., Galectin-1 is part of human trophoblast invasion machinery - a functional study in vitro (2011) PLoS ONE, 6, pp. e28514
• Kolundzic, N., Galectin-8 is expressed by villous and extravillous trophoblast of the human placenta (2011) Placenta, 32, pp. 909-911
• Koopman, L.A., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential (2003) J. Exp. Med., 198, pp. 1201-1212
• Kopcow, H.D., T cell apoptosis at the maternal-fetal interface in early human pregnancy involvement of galectin-1 (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 18472-18477
• Kuang, H., Hormonal regulation of uterine natural killer cells in mouse preimplantation uterus (2010) J. Mol. Histol., 41, pp. 1-7
• Lindheimer, M.D., Ash position paper: hypertension in pregnancy (2009) J. Clin. Hypertens. (Greenwich), 11, pp. 214-225
• Liu, A.X., Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss (2006) Biol. Reprod., 75, pp. 414-420
• Liu, F.T., Intracellular functions of galectins (2002) Biochim. Biophys. Acta, 1572, pp. 263-273
• Maquoi, E., Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts (1997) Placenta, 18, pp. 433-439
• Moffett-King, A., Natural killer cells and pregnancy (2002) Nat. Rev. Immunol., 2, pp. 656-663
• Molvarec, A., Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia (2011) Clin. Immunol., 139, pp. 48-56
• Nickel, W., Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells (2005) Traffic, 6, pp. 607-614
• Nicolaides, K.H., A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound (2006) Ultrasound Obstet. Gynecol., 27, pp. 13-17
• Nishi, N., Galectin-8 modulates neutrophil function via interaction with integrin alpham (2003) Glycobiology, 13, pp. 755-763
• Ogawa, M., Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key (2007) Placenta, 28, pp. 224-232
• Oomizu, S., Galectin-9 suppresses Th17 cell development in an IL-2-dependent but TIM-3-independent manner (2012) Clin. Immunol., 143, pp. 51-58
• Phillips, B., Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice (1996) Biol. Reprod., 55, pp. 548-558
• Popovici, R.M., Galectin-9: a new endometrial epithelial marker for the mid- and late-secretory and decidual phases in humans (2005) J. Clin. Endocrinol. Metab., 90, pp. 6170-6176
• Powe, C.E., Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease (2011) Circulation, 123, pp. 2856-2869
• Rabinovich, G.A., An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer (2007) Scand. J. Immunol., 66, pp. 143-158
• Redman, C.W., Immunological aspects of pre-eclampsia (1992) Baillieres Clin. Obstet. Gynaecol., 6, pp. 601-615
• Redman, C.W., Sargent, I.L., Circulating microparticles in normal pregnancy and pre-eclampsia (2008) Placenta, 29 (SUPPL A), pp. S73-S77
• Redman, C.W., Sargent, I.L., Placental stress and pre-eclampsia: a revised view (2009) Placenta, 30 (SUPPL A), pp. S38-S42
• Redman, C.W., Sargent, I.L., Immunology of pre-eclampsia (2010) Am. J. Reprod. Immunol., 63, pp. 534-543
• Redman, C.W., Preeclampsia: an excessive maternal inflammatory response to pregnancy (1999) Am. J. Obstet. Gynecol., 180, pp. 499-506
• Sammar, M., Placenta-bound and body fluid PP13 and its MRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery (2011) Placenta, 32 (SUPPL), pp. S30-S36
• Sargent, I.L., Immunoregulation in normal pregnancy and pre-eclampsia: an overview (2007) Reprod. Biomed. Online, 14, pp. 111-117. , Spec No. 1
• Sekizawa, A., PP13 MRNA expression in trophoblasts from preeclamptic placentas (2009) Reprod. Sci., 16, pp. 408-413
• Shimizu, H., PP13 MRNA expression in the cellular component of maternal blood as a marker for preeclampsia (2009) Prenat. Diagn., 29, pp. 1231-1236
• Sibai, B.M., Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis (1991) Am. J. Obstet. Gynecol., 165, pp. 1408-1412
• Sibai, B.M., Preeclampsia as a cause of preterm and late preterm (near-term) births (2006) Semin. Perinatol., 30, pp. 16-19
• Staff, A.C., Redefining preeclampsia using placenta-derived biomarkers (2013) Hypertension, 61, pp. 932-942
• Stillman, B.N., Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce t cell death (2006) J. Immunol., 176, pp. 778-789
• Than, N.G., Isolation and sequence analysis of a cdna encoding human placental tissue protein 13 (pp13) a new lysophospholipase, homologue of human eosinophil charcot-leyden crystal protein (1999) Placenta, 20, pp. 703-710
• Than, N.G., Functional analyses of placental protein 13/galectin-13 (2004) Eur. J. Biochem., 271, pp. 1065-1078
• Than, N.G., Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome (2008) Virchows Arch., 453, pp. 387-400
• Than, N.G., Severe preeclampsia is characterized by increased placental expression of galectin-1 (2008) J. Matern. Fetal Neonatal Med., 21, pp. 429-442
• Than, N.G., A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 9731-9736
• Thijssen, V.L., The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells (2008) Am. J. Pathol., 172, pp. 545-553
• Thijssen, V.L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res., 70, pp. 6216-6224
• Tirado-Gonzalez, I., Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy (2013) Mol. Hum. Reprod., 19, pp. 43-53
• Tribulatti, M.V., Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of t cell responses (2012) J. Immunol., 188, pp. 2991-2999
• Vicovac, L., Galectin-1 and -3 in cells of the first trimester placental bed (1998) Hum. Reprod., 13, pp. 730-735
• Vince, G.S., Interleukin-6 tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia (1995) Br. J. Obstet. Gynaecol., 102, pp. 20-25
• Von Dadelszen, P., Subclassification of preeclampsia (2003) Hypertens Pregnancy, 22, pp. 143-148
• Von Wolff, M., Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation (2005) Mol. Hum. Reprod., 11, pp. 189-194
• Wortelboer, E.J., First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia (2010) BJOG, 117, pp. 1384-1389
• Yamamoto, H., Induction of cell adhesion by galectin-8 and its target molecules in Jurkat T-cells (2008) J. Biochem., 143, pp. 311-324
• Yang, H., Expression of galectin-3 in mouse endometrium and its effect during embryo implantation (2012) Reprod. Biomed. Online, 24, pp. 116-122
• Yang, R.Y., Expression of galectin-3 modulates T-cell growth and apoptosis (1996) Proc. Natl. Acad. Sci. U.S.A., 93, pp. 6737-6742
• Zhao, X.Y., Synergistic induction of galectin-1 by ccaat/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells (2011) J. Biol. Chem., 286, pp. 36808-36819
• Zhu, C., TIM-3 and its regulatory role in immune responses (2011) Curr. Top. Microbiol. Immunol., 350, pp. 1-15
• Zick, Y., Role of galectin-8 as a modulator of cell adhesion and cell growth (2004) Glycoconj. J., 19, pp. 517-526

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------